Brief: Schott Pharma FY Net Profit Down 1% At EUR 150 Million

SCHOTT Pharma AG & Co KgaA

12/12/2024 06:05

Dec 12 (Reuters) - SCHOTT Pharma AG & Co KgaA  1SXP.DE :
    * EQS-NEWS: SCHOTT PHARMA WITH STRONG GROWTH AND RECORD
MARGIN
AFTER SOLID YEAR-END FINISH
    * SCHOTT PHARMA AG & CO KGAA - GUIDANCE FOR FY 2025 REFLECTS
FURTHER STRONG REVENUE AND EARNINGS GROWTH AT CONSTANT
CURRENCIES
    * SCHOTT PHARMA AG & CO KGAA - Q4 2024 REVENUES REACH EUR
237M,
EBITDA MARGIN 27.9%
    * SCHOTT PHARMA AG & CO KGAA - FY 2024 REVENUES REACH EUR
957M,
EBITDA MARGIN 26.9%
    * SCHOTT PHARMA AG & CO KGAA - FY 2024 EBITDA INCREASES 8%
YOY TO
EUR 258M
    * SCHOTT PHARMA AG & CO KGAA - FY 2024 FREE CASH FLOW
REACHES EUR
79M
    * SCHOTT PHARMA AG & CO KGAA - FY NET PROFIT AFTER
MINORITIES CAME
IN AT EUR 150M, A SLIGHT DECLINE OF 1% YOY.

Source text:  ID:nEQCGmmNa 
Further company coverage:  1SXP.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))